跳转到内容

齐雷索韦

维基百科,自由的百科全书
齐雷索韦
臨床資料
商品名英语Drug nomenclatureZiresovir
法律規範狀態
法律規範
  • Investigational New Drug
识别信息
  • N-[(3-aminooxetan-3-yl)methyl]-2-(1,1-dioxo-3,5-dihydro-2H-1λ6,4-benzothiazepin-4-yl)-6-methylquinazolin-4-amine
CAS号1422500-60-4
PubChem CID
ChemSpider
UNII
化学信息
化学式C22H25N5O3S
摩尔质量439.5
3D模型(JSmol英语JSmol
  • CC1=CC2=C(C=C1)N=C(N=C2NCC3(COC3)N)N4CCS(=O)(=O)C5=CC=CC=C5C4
  • InChI=1S/C22H25N5O3S/c1-15-6-7-18-17(10-15)20(24-12-22(23)13-30-14-22)26-21(25-18)27-8-9-31(28,29)19-5-3-2-4-16(19)11-27/h2-7,10H,8-9,11-14,23H2,1H3,(H,24,25,26)
  • Key:GAAICKUTDBZCMT-UHFFFAOYSA-N

齐雷索韦(ziresovir、RO-0529AK0529,化学式C22H25N5O3S)是一种抗病毒药,被开发用于治疗呼吸道合胞病毒感染。它作为一种融合抑制剂,在II期临床试验中显示出较好的疗效。[1][2]

参见

[编辑]

参考文献

[编辑]
  1. ^ Zheng X, Gao L, Wang L, Liang C, Wang B, Liu Y, Feng S, Zhang B, Zhou M, Yu X, Xiang K, Chen L, Guo T, Shen HC, Zou G, Wu JZ, Yun H. Discovery of Ziresovir as a Potent, Selective, and Orally Bioavailable Respiratory Syncytial Virus Fusion Protein Inhibitor. J Med Chem. 2019 Jul 11;62(13):6003-6014. doi:10.1021/acs.jmedchem.9b00654 PMID 31194544
  2. ^ Beigel JH, Nam HH, Adams PL, Krafft A, Ince WL, El-Kamary SS, Sims AC. Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference. Antiviral Res. 2019 Jul;167:45-67. PMID 30974127 doi:10.1016/j.antiviral.2019.04.006